Trent LPS17007 Pre-Screen
  • Pre-screening form for A 24-Week, Multicenter, Randomized, Open-Label, Parallel-Group Trial Comparing the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (IDeg-100) in Insulin-Naïve People with Type 2 Diabetes Mellitus and Renal Impairment:

    Trent LPS17007
  • Date of Birth*
     - -
  • Format: (000) 000-0000.
  • Have you been diagnosed with Type 2 Diabetes Mellitus for at least 1 year?*
  • When were your most recent blood lab results taken?*
  • Should be Empty: